Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Inulin on Intestinal Symptoms, Depression and Quality of Life in Individuals With Constipation-Predominant Irritable Bowel Syndrome

NCT06610188 is registered in ClinicalTrials.gov with Mardin Artuklu University as lead sponsor.

NCT NCT06610188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06610188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Inulin on Intestinal Symptoms, Depression and Quality of Life in Individuals With Constipation-Predominant Irritable Bowel Syndrome
Lead sponsor
Mardin Artuklu University
Phase
Not applicable
Overall status
Completed
Start date
November 3, 2021
Completion date
April 1, 2023
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bowel symptoms, constipation, depression disorders, inulin, irritable bowel syndrome (ibs), quality of life (qol)